Go Pro
→ Buy this stock today (From Chaikin Analytics) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Azenta, Inc. stock logo
AZTA
Azenta
$33.38
-1.6%		$26.65
$15.93
▼
$41.73
$1.49B1.37664,983 shs497,776 shs
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$35.07
-0.5%		$29.39
$17.86
▼
$35.35
$1.72B1.931.54 million shs478,677 shs
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
$17.41
-2.3%		$17.72
$7.40
▼
$21.39
$1.69B1.991.68 million shs2.56 million shs
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$106.04
-6.3%		$100.64
$58.83
▼
$115.52
$633.45M0.92147,868 shs161,033 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Azenta, Inc. stock logo
AZTA
Azenta
-1.56%+4.18%+24.97%+108.36%+4.05%
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-0.45%+1.18%+20.31%+68.93%+36.57%
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
-2.30%-5.53%-2.79%+27.45%+122.07%
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
-6.33%+3.30%+12.00%+9.92%+53.06%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Azenta, Inc. stock logo
AZTA
Azenta
$33.38
-1.6%		$26.65
$15.93
▼
$41.73
$1.49B1.37664,983 shs497,776 shs
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$35.07
-0.5%		$29.39
$17.86
▼
$35.35
$1.72B1.931.54 million shs478,677 shs
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
$17.41
-2.3%		$17.72
$7.40
▼
$21.39
$1.69B1.991.68 million shs2.56 million shs
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$106.04
-6.3%		$100.64
$58.83
▼
$115.52
$633.45M0.92147,868 shs161,033 shs
7 Stocks That Could Lead the Next Market Boom Cover
7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Azenta, Inc. stock logo
AZTA
Azenta
-1.56%+4.18%+24.97%+108.36%+4.05%
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-0.45%+1.18%+20.31%+68.93%+36.57%
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
-2.30%-5.53%-2.79%+27.45%+122.07%
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
-6.33%+3.30%+12.00%+9.92%+53.06%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Azenta, Inc. stock logo
AZTA
Azenta
2.43
Hold$41.2023.43% Upside
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
2.18
Hold$31.38-10.54% Downside
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
2.33
Hold$20.7519.18% Upside
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
2.00
Hold$110.003.73% Upside

Current Analyst Ratings Breakdown

Latest MLAB, FTRE, BLFS, and AZTA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/14/2026
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$94.00 ➝ $110.00
8/11/2026
Azenta, Inc. stock logo
AZTA
Azenta
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/11/2026
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D) ➝ Hold (C-)
8/10/2026
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
Benchmark Co. logo
Benchmark
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold
8/5/2026
Azenta, Inc. stock logo
AZTA
Azenta
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$33.00 ➝ $37.00
8/4/2026
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$19.00 ➝ $23.00
8/4/2026
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
7/31/2026
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$20.00 ➝ $22.00
7/30/2026
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
Deutsche Bank Aktiengesellschaft logo
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold$20.00
7/30/2026
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$23.00
7/30/2026
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$18.00 ➝ $22.00
(Data available from 8/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Azenta, Inc. stock logo
AZTA
Azenta
$593.82M2.46$1.78 per share18.71$34.47 per share0.97
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$96.21M17.81$0.23 per share153.85$8.60 per share4.08
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
$2.68B0.62$9.67 per share1.80$5.51 per share3.16
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$249.13M2.38$11.03 per share9.61$33.73 per share3.14
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Azenta, Inc. stock logo
AZTA
Azenta
-$55.76M-$2.76N/AN/AN/A-20.63%1.18%0.97%N/A
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
-$4.59M$1.1630.23219.19N/A53.29%2.70%2.49%N/A
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
-$986.20M-$0.91N/A16.420.43-3.18%10.72%2.17%N/A
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$6.71M$0.84126.24N/AN/A1.92%22.72%9.82%N/A

Latest MLAB, FTRE, BLFS, and AZTA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/10/2026Q1 2027
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
N/A$2.68N/A$0.49N/A$60.14 million
8/6/2026Q2 2026
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
$0.0313$0.91+$0.8788$0.91$27.80 million$28.47 million
8/4/2026Q3 2026
Azenta, Inc. stock logo
AZTA
Azenta
$0.1138$0.16+$0.0462$0.05$149.31 million$161.18 million
7/29/2026Q2 2026
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
$0.1804$0.23+$0.0496-$0.14$647.57 million$678.20 million
5/27/2026Q4 2026
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$1.78$1.53-$0.25-$0.75$65.21 million$63.72 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Azenta, Inc. stock logo
AZTA
Azenta
N/AN/A-100.00%N/AN/A
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
N/AN/AN/AN/AN/A
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
N/AN/AN/AN/AN/A
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$0.640.60%N/A76.19%N/A

Latest MLAB, FTRE, BLFS, and AZTA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/6/2026
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
quarterly$0.160.62%8/31/20268/31/20269/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Azenta, Inc. stock logo
AZTA
Azenta
N/A
2.50
2.21
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
N/A
9.69
7.14
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
1.98
0.96
0.96
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
0.73
1.79
1.29

Institutional Ownership

CompanyInstitutional Ownership
Azenta, Inc. stock logo
AZTA
Azenta
99.08%
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
93.24%
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
N/A
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
90.60%

Insider Ownership

CompanyInsider Ownership
Azenta, Inc. stock logo
AZTA
Azenta
10.90%
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
2.20%
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
0.73%
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
2.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Azenta, Inc. stock logo
AZTA
Azenta
3,00043.81 million39.03 millionOptionable
BioLife Solutions, Inc. stock logo
BLFS
BioLife Solutions
44048.86 million47.78 millionOptionable
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
14,30095.10 million94.41 millionOptionable
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
6805.60 million5.44 millionNot Optionable

Recent News About These Companies

Mesa Laboratories (NASDAQ:MLAB) Lowered to Buy Rating by Wall Street Zen
 |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30961434
Mesa Laboratories (NASDAQ:MLAB) Rating Lowered to Buy at Wall Street Zen
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/mesa-laboratories-nasdaqmlab-rating-lowered-to-buy-at-wall-street-zen-2026-08-15/
Mesa Laboratories (NASDAQ:MLAB) Stock Price Down 6% - Time to Sell?
August 14 at 3:59 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/mesa-laboratories-nasdaqmlab-stock-price-down-6-time-to-sell-2026-08-14/
Mesa Laboratories (NASDAQ:MLAB) Given New $110.00 Price Target at Wells Fargo & Company
August 14 at 11:05 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/mesa-laboratories-nasdaqmlab-given-new-11000-price-target-at-wells-fargo-company-2026-08-14/
Mesa Laboratories (NASDAQ:MLAB) Hits New 12-Month High - Here's Why
August 13 at 1:19 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/mesa-laboratories-nasdaqmlab-hits-new-12-month-high-heres-why-2026-08-13/
Wasatch Advisors LP Increases Position in Mesa Laboratories, Inc. $MLAB
August 13 at 5:22 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-wasatch-advisors-lp-increases-position-in-mesa-laboratories-inc-mlab-2026-08-13/
Mesa Laboratories targets 1.5–1.75x net leverage by fiscal 2027 exit while resetting Gyrolab launch to fiscal 2028
August 12 at 7:43 AM  |  seekingalpha.comhttps://seekingalpha.com/news/4630401-mesa-laboratories-targets-1_5-1_75x-net-leverage-by-fiscal-2027-exit-while-resetting-gyrolab
Mesa Laboratories (NASDAQ:MLAB) Sees Large Volume Increase - What's Next?
August 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/mesa-laboratories-nasdaqmlab-sees-large-volume-increase-whats-next-2026-08-11/
Mesa Laboratories, Inc. (MLAB) Q1 2027 Earnings Call Transcript
August 10, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4934313-mesa-laboratories-inc-mlab-q1-2027-earnings-call-transcript
Mesa Laboratories Q1 Earnings Call Highlights
August 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/mesa-laboratories-q1-earnings-call-highlights-2026-08-10/
Mesa Laboratories (MLAB) Releases Q1 2027 Earnings: Revenue Growth but EPS Declines
August 10, 2026  |  quiverquant.comQ
Mesa Laboratories (NASDAQ:MLAB) Issues Earnings Results, Misses Expectations By $2.14 EPS
August 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/mesa-laboratories-nasdaqmlab-issues-earnings-results-misses-expectations-by-214-eps-2026-08-10/
Renaissance Technologies LLC Has $2.79 Million Holdings in Mesa Laboratories, Inc. $MLAB
August 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-renaissance-technologies-llc-has-279-million-holdings-in-mesa-laboratories-inc-mlab-2026-08-10/
Janus Henderson Group PLC Cuts Holdings in Mesa Laboratories, Inc. $MLAB
August 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-janus-henderson-group-plc-cuts-holdings-in-mesa-laboratories-inc-mlab-2026-08-07/
Lazard Asset Management LLC Buys New Stake in Mesa Laboratories, Inc. $MLAB
August 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-lazard-asset-management-llc-buys-new-stake-in-mesa-laboratories-inc-mlab-2026-08-04/
Mesa Labs Announces First Quarter Financial Results Release Date and Inaugural Earnings Conference Call
August 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/03/3337432/30771/en/mesa-labs-announces-first-quarter-financial-results-release-date-and-inaugural-earnings-conference-call.html
Mesa Laboratories (MLAB) Projected to Release Earnings on Monday
August 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/mesa-laboratories-mlab-projected-to-release-earnings-on-monday-2026-08-03/
Mesa Laboratories (NASDAQ:MLAB) Stock Price Passes Above 200 Day Moving Average - Here's What Happened
July 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/mesa-laboratories-nasdaqmlab-stock-price-passes-above-200-day-moving-average-heres-what-happened-2026-07-31/
Globeflex Capital L P Invests $958,000 in Mesa Laboratories, Inc. $MLAB
July 23, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-globeflex-capital-l-p-invests-958000-in-mesa-laboratories-inc-mlab-2026-07-23/
Mesa Laboratories, Inc. $MLAB Shares Purchased by Roubaix Capital LLC
July 19, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-mesa-laboratories-inc-mlab-shares-purchased-by-roubaix-capital-llc-2026-07-19/
Mesa Laboratories declares $0.16 dividend
July 6, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4611740-mesa-laboratories-declares-0_16-dividend?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=news?source=MarketBeat

New MarketBeat Followers Over Time

Media Sentiment Over Time

Azenta stock logo

Azenta NASDAQ:AZTA

$33.38 -0.53 (-1.56%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$33.33 -0.05 (-0.15%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

BioLife Solutions stock logo

BioLife Solutions NASDAQ:BLFS

$35.07 -0.16 (-0.45%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$35.28 +0.20 (+0.58%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

Fortrea stock logo

Fortrea NASDAQ:FTRE

$17.41 -0.41 (-2.30%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$17.38 -0.03 (-0.18%)
As of 08/14/2026 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

Mesa Laboratories stock logo

Mesa Laboratories NASDAQ:MLAB

$106.04 -7.16 (-6.33%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$106.16 +0.11 (+0.11%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas